|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/46 | |
| A61K 35/76 | |||
| A61P 35/00 | |||
| C07K 14/14 | |||
| C12N 15/86 | |||
| C12N 7/01 |
| (11) | Patento numeris | 2132315 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08733587.3 |
| Europos patento paraiškos padavimo data | 2008-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2008/000483 |
| Data | 2008-03-11 |
| (87) | Numeris | WO 2008/110004 |
| Data | 2008-09-18 |
| (30) | Numeris | Data | Šalis |
| 894425 P | 2007-03-12 | US | |
| 989568 P | 2007-11-21 | US |
| (72) |
COFFEY, Matthew C., CA
|
| (73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
| (54) | REOVIRUSES HAVING MODIFIED SEQUENCES |
| REOVIRUSES HAVING MODIFIED SEQUENCES |